Pharmaceuticals news FT.com

The cost of Trump’s attack on American science

Sweeping funding cuts threaten to undermine the innovation that has been a central part of US economic strength for decades

May 12, 2025 - 10:14
 0
The cost of Trump’s attack on American science
Sweeping funding cuts threaten to undermine the innovation that has been a central part of US economic strength for decades
Read More

Tags:

Previous Article

Pharma bosses call for higher drug prices in EU to counter tariff threat

Next Article

Roche to spend $50bn on US manufacturing and R&D

Related Posts

Trump vows to lower US drug prices by up to 80%

Trump vows to lower US drug prices by up to 80%

May 12, 2025  0

23andMe founder says Fortune 500 company backs new buyout offer

23andMe founder says Fortune 500 company backs new buyo...

Jun 1, 2025  0

GSK buys Boston Pharmaceutical’s new liver disease drug for up to $2bn

GSK buys Boston Pharmaceutical’s new liver disease drug...

May 14, 2025  0